adg-126
adagene
['adg126 ', 'adg126', 'adagene']
adagene presents interim monotherapy data at esmo 2022 showing compelling safety, anti-tumor activity and pharmacokinetics of masked, anti-ctla-4 safebody adg126 in patients with advanced tumors 
Pharmaceutical News - Direct Information